PUBMED FOR HANDHELDS

Journal Abstract Search


1322 related items for PubMed ID: 22902358

  • 21. The postoperative cortisol stress response following transsphenoidal pituitary surgery: a potential screening method for assessing preserved pituitary function.
    Zada G, Tirosh A, Huang AP, Laws ER, Woodmansee WW.
    Pituitary; 2013 Sep; 16(3):319-25. PubMed ID: 22915289
    [Abstract] [Full Text] [Related]

  • 22. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
    Invitti C, Pecori Giraldi F, de Martin M, Cavagnini F.
    J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
    [Abstract] [Full Text] [Related]

  • 23. [Predictors of long-term remission after transsphenoidal surgery in Cushing's disease].
    Abellán Galiana P, Fajardo Montañana C, Riesgo Suárez PA, Gómez Vela J, Escrivá CM, Lillo VR.
    Endocrinol Nutr; 2013 Oct; 60(8):475-82. PubMed ID: 23266144
    [Abstract] [Full Text] [Related]

  • 24. Long-term outcomes of tissue-based ACTH-antibody assay-guided transsphenoidal resection of pituitary adenomas in Cushing disease.
    Erfe JM, Perry A, McClaskey J, Inzucchi SE, James WS, Eid T, Bronen RA, Mahajan A, Huttner A, Santos F, Spencer D.
    J Neurosurg; 2018 Sep; 129(3):629-641. PubMed ID: 29027854
    [Abstract] [Full Text] [Related]

  • 25. Postoperative plasma cortisol levels predict long-term outcome in patients with Cushing's disease and determine which patients should be treated with pituitary irradiation after surgery.
    Imaki T, Tsushima T, Hizuka N, Odagiri E, Murata Y, Suda T, Takano K.
    Endocr J; 2001 Feb; 48(1):53-62. PubMed ID: 11403103
    [Abstract] [Full Text] [Related]

  • 26. Clinical review: Early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing's disease.
    Esposito F, Dusick JR, Cohan P, Moftakhar P, McArthur D, Wang C, Swerdloff RS, Kelly DF.
    J Clin Endocrinol Metab; 2006 Jan; 91(1):7-13. PubMed ID: 16234305
    [Abstract] [Full Text] [Related]

  • 27. Morbidity of repeat transsphenoidal surgery assessed in more than 1000 operations.
    Jahangiri A, Wagner J, Han SW, Zygourakis CC, Han SJ, Tran MT, Miller LM, Tom MW, Kunwar S, Blevins LS, Aghi MK.
    J Neurosurg; 2014 Jul; 121(1):67-74. PubMed ID: 24834943
    [Abstract] [Full Text] [Related]

  • 28. Comparison of one week 0900 h serum cortisol, low and standard dose synacthen tests with a 4 to 6 week insulin hypoglycaemia test after pituitary surgery in assessing HPA axis.
    Courtney CH, McAllister AS, McCance DR, Bell PM, Hadden DR, Leslie H, Sheridan B, Atkinson AB.
    Clin Endocrinol (Oxf); 2000 Oct; 53(4):431-6. PubMed ID: 11012567
    [Abstract] [Full Text] [Related]

  • 29. Use of day 1 early morning cortisol to predict the need for glucocorticoid replacement after pituitary surgery.
    Bondugulapati LN, Campbell C, Chowdhury SR, Goetz P, Davies JS, Rees DA, Hayhurst C.
    Br J Neurosurg; 2016 Oct; 30(1):76-9. PubMed ID: 26313503
    [Abstract] [Full Text] [Related]

  • 30. Peri-operative glucocorticoid replacement therapy in transsphenoidal pituitary adenoma surgery: a prospective controlled study.
    Kristof RA, Wichers M, Haun D, Redel L, Klingmüller D, Schramm J.
    Acta Neurochir (Wien); 2008 Apr; 150(4):329-35; discussion 335. PubMed ID: 18309452
    [Abstract] [Full Text] [Related]

  • 31. Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing's disease.
    Storr HL, Afshar F, Matson M, Sabin I, Davies KM, Evanson J, Plowman PN, Besser GM, Monson JP, Grossman AB, Savage MO.
    Eur J Endocrinol; 2005 Jun; 152(6):825-33. PubMed ID: 15941921
    [Abstract] [Full Text] [Related]

  • 32. Dynamics of postoperative serum cortisol after transsphenoidal surgery for Cushing's disease: implications for immediate reoperation and remission.
    Mayberg M, Reintjes S, Patel A, Moloney K, Mercado J, Carlson A, Scanlan J, Broyles F.
    J Neurosurg; 2018 Nov 01; 129(5):1268-1277. PubMed ID: 29271716
    [Abstract] [Full Text] [Related]

  • 33. Rational use of glucocorticoid during pituitary surgery--a pilot study.
    Bhansali A, Dutta P, Bhat MH, Mukherjee KK, Rajput R, Bhadada S.
    Indian J Med Res; 2008 Sep 01; 128(3):294-9. PubMed ID: 19052341
    [Abstract] [Full Text] [Related]

  • 34. Can basal cortisol measurement be an alternative to the insulin tolerance test in the assessment of the hypothalamic-pituitary-adrenal axis before and after pituitary surgery?
    Karaca Z, Tanriverdi F, Atmaca H, Gokce C, Elbuken G, Selcuklu A, Unluhizarci K, Kelestimur F.
    Eur J Endocrinol; 2010 Sep 01; 163(3):377-82. PubMed ID: 20530552
    [Abstract] [Full Text] [Related]

  • 35. ACTH adenomas transforming their clinical expression: report of 5 cases.
    Zoli M, Faustini-Fustini M, Mazzatenta D, Marucci G, De Carlo E, Bacci A, Pasquini E, Lanzino G, Frank G.
    Neurosurg Focus; 2015 Feb 01; 38(2):E15. PubMed ID: 25639317
    [Abstract] [Full Text] [Related]

  • 36. Endoscopic endonasal transsphenoidal surgery for functional pituitary adenomas.
    Hofstetter CP, Shin BJ, Mubita L, Huang C, Anand VK, Boockvar JA, Schwartz TH.
    Neurosurg Focus; 2011 Apr 01; 30(4):E10. PubMed ID: 21456921
    [Abstract] [Full Text] [Related]

  • 37. Perioperative serum cortisol levels in ACTH sufficient and ACTH deficient patients during transsphenoidal surgery of pituitary adenoma.
    Borg H, Siesjö P, Kahlon B, Fjalldal S, Erfurth EM.
    Endocrine; 2018 Oct 01; 62(1):83-89. PubMed ID: 29968225
    [Abstract] [Full Text] [Related]

  • 38. Recovery Room Cortisol Predicts Long-Term Glucocorticoid Need After Transsphenoidal Surgery for Pituitary Tumors.
    Qaddoura A, Shalung TN, Meier MP, Goguen J, Jing R, Zhang S, Kovacs K, Cusimano MD.
    Neurosurgery; 2019 Mar 01; 84(3):616-623. PubMed ID: 30767017
    [Abstract] [Full Text] [Related]

  • 39. Evaluation of a perioperative steroid coverage after pituitary surgery.
    Irigaray Echarri A, Ollero García-Agulló MD, Iriarte Beroiz A, García Mouriz M, Zazpe Cenoz I, Laguna Muro S, Muñoz de Dios L, Anda Apiñániz E.
    Endocrinol Diabetes Nutr (Engl Ed); 2022 May 01; 69(5):338-344. PubMed ID: 35538002
    [Abstract] [Full Text] [Related]

  • 40. Recovery of the Hypothalamo-Pituitary-Adrenal Axis After Transsphenoidal Adenomectomy for Non-ACTH-Secreting Macroadenomas.
    Pofi R, Gunatilake S, Macgregor V, Shine B, Joseph R, Grossman AB, Isidori AM, Cudlip S, Jafar-Mohammadi B, Tomlinson JW, Pal A.
    J Clin Endocrinol Metab; 2019 Nov 01; 104(11):5316-5324. PubMed ID: 31225871
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 67.